SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp. engages in the design, manufacture, and launch of rockets and spacecrafts. It provides satellite communication services. The company was founded by Elon Reeve Musk on March 14, 2002 and is headquartered in Hawthorne, CA.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is generating massive market buzz following its high-profile public debut, with investors deeply divided over whether the company's multi-trillion dollar valuation reflects revolutionary long-term potential or unsustainable hype. The community is actively debating the stock's future, as traders closely monitor high volatility and look ahead to upcoming options trading, index inclusion, and the potential impact of insider lock-up expirations.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending as the community closely monitors the progress of its $110 billion acquisition of Warner Bros. Discovery following the Department of Justice's approval. Shareholders are actively debating the potential for long-term synergy value, the impact of ongoing regulatory reviews in Europe, and the strategic implications of management's integration plans while remaining focused on upcoming deal closing milestones.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku is trending following a Bloomberg report that the streaming company is exploring a potential sale, with discussions reportedly underway with at least one major U.S. media entity. The community is actively debating the credibility of these buyout rumors and the company's long-term strategic value, leading to significant volatility as traders analyze the potential for a premium acquisition against the backdrop of an increasingly competitive streaming landscape.

Entrepreneurshares Series Trust - ERShares Private-Public Crossover ETF

Investors are expressing frustration over the ETF's lack of upward momentum despite its concentrated holding in SpaceX, with many in the community debating the impact of the fund's SPV-based valuation structure versus direct equity exposure. Discussions focus on whether the market is discounting the fund's private asset holdings ahead of a broader public launch or if the current price action reflects concerns regarding transparency and the fund's long-term growth potential.

Amkor Technology, Inc. engages in the provision of outsourced semiconductor packaging and test services. Its services include design, package characterization, test, and wafer bumping services. The company was founded in 1968 and is headquartered in Tempe, AZ.

AMKOR Technology Inc.

Amkor Technology is trending as the stock surges following a major announcement that it is breaking ground on an expanded multi-billion dollar semiconductor packaging campus in Arizona. The community is actively discussing this expansion as a key play on domestic semiconductor onshoring and the growing necessity of advanced packaging to support the AI supply chain.

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

ARS Pharmaceuticals is trending as its competitor Aquestive Therapeutics faces a regulatory setback regarding their Anaphylm treatment, solidifying SPRY's position as the sole provider of an FDA-approved, needle-free epinephrine solution. Investors are actively discussing the potential for a significant short squeeze given the stock's high short interest and the removal of near-term competitive pressure.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as investors debate the potential for future adoption versus extreme price volatility and frustration over a lack of major updates from the Flexa team. While community sentiment is heavily polarized between long-term holders citing the utility of the Anvil and Flexa ecosystem and critics pointing to the token's persistent downward trend, active discussions remain focused on legislative catalysts like the CLARITY Act and alleged institutional activity in staking pools.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is facing significant downward pressure and high volatility as investors rotate capital out of existing sector names to gain exposure to the high-profile SpaceX public listing. While some market participants express concern over valuation and execution timelines, many in the community view this pullback as a temporary liquidity event and are actively looking to accumulate positions ahead of upcoming satellite launch catalysts.

Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment develops and manufactures a broad range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. The Specialties segment focuses on optimizing a portfolio of bromine and specialized lithium solutions. The Ketjen segment consists of clean fuels technologies, fluidized catalytic cracking catalysts and additives, and performance catalyst solutions, which is primarily composed of organometallics and curatives. The company was founded in 1993 and is headquartered in Charlotte, NC.

Albemarle Corp.

Albemarle Corp

Albemarle Corporation is trending as investors respond to stabilizing lithium prices, rebounding energy storage demand, and improved earnings outlooks that have spurred a series of analyst upgrades. The community is actively discussing the stock's recent bullish breakout, with many investors debating whether to lock in profits from the significant recovery or hold for further gains amid a perceived shift in the lithium market cycle.

The TROLL token on the Solana network is a meme coin inspired by internet trolling culture, designed for entertainment and community engagement with no intrinsic value. Built on Solana’s blockchain, it leverages the network’s fast transactions and low fees to appeal to meme enthusiasts. Launched on decentralized exchanges, TROLL aims to foster a fun, community-driven ecosystem through social media, influencer partnerships, and viral marketing, embodying the playful spirit of online trolling.

Troll

TROLL is capturing significant community attention as investors position it alongside established meme coins, with many touting its long-standing cultural relevance and potential for exponential growth. Enthusiasm is centered on the project's ownership of original IP rights and active grassroots campaigns aimed at driving massive adoption within the broader meme ecosystem.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Institutional Confidence in GTX-102 Fuels Optimism for Ultragenyx Pharmaceutical (RARE)

Institutional Confidence in GTX-102 Fuels Optimism for Ultragenyx Pharmaceutical (RARE...

Kuehn Law Encourages Investors of Ultragenyx Pharmaceutical Inc. to Contact Law Firm

Kuehn Law Encourages Investors of Ultragenyx Pharmaceutical Inc. to Contact Law Firm Kuehn Law Encourages Investors of Ultragenyx Pharmaceutical Inc. to Contact Law Firm PR Newswire NEW YORK, June 4, 2026 NEW YORK, June 4, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is...

Ultragenyx (RARE) Down 13.6% Since Last Earnings Report: Can It Rebound?

Ultragenyx (RARE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year

Key PointsKrensavage bought 241,245 Ultragenyx Pharmaceutical shares last quarter...

RARE Q1 Loss Wider Than Expected, Sales Down Y/Y on Seasonal Effect

Ultragenyx posts a wider-than-expected Q1 loss as Crysvita sales fall on seasonal effects, while Evkeeza and Dojolvi revenue growth partially offset declines.

Wells Fargo & Company Issues Positive Forecast for Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock Price

Wells Fargo & Company upped their price target on Ultragenyx Pharmaceutical from $45.00 to $47.00 and gave the company an "overweight" rating in a research report on Wednesday...

Wedbush Issues Pessimistic Forecast for Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock Price

Wedbush dropped their price objective on Ultragenyx Pharmaceutical from $27.00 to $26.00 and set a 'neutral' rating for the company in a research report on Wednesday...

Universal Beteiligungs und Servicegesellschaft mbH Has $323,000 Position in Ultragenyx Pharmaceutical Inc. $RARE

Universal Beteiligungs und Servicegesellschaft mbH decreased its position in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE - Free Report) by 84.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 14,094 shares of the...

Ultragenyx Pharmaceutical Q1 Earnings Call Highlights

Ultragenyx Pharmaceutical (NASDAQ:RARE) executives said the company is positioned for what Chief Executive Officer Emil Kakkis described as a "transformative" year, pointing to expectations for growing revenue, potential approvals for two gene therapies, and a key late-stage readout for its Angelman...

Ultragenyx Pharmaceutical (NASDAQ:RARE) Releases Earnings Results, Beats Expectations By $1,000.50 EPS

Ultragenyx Pharmaceutical (NASDAQ:RARE - Get Free Report) announced its quarterly earnings data on Tuesday. The biopharmaceutical company reported $999.00 EPS for the quarter, beating analysts' consensus estimates of ($1.50) by $1,000.50. Ultragenyx Pharmaceutical had a negative return on equity of...

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

RAREUltragenyx Pharmaceutical Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RARE News